![](https://i0.wp.com/hrnxt.com/wp-content/uploads/2021/04/Sputnik-v.jpg?resize=200%2C112&ssl=1)
The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund), and Wockhardt Limited, a global pharmaceutical company headquartered in India, have partnered to produce and supply Sputnik V and Sputnik Light vaccines against COVID-19. The agreement was reached under the aegis of Enso Healthcare (part of Enso Group), RDIF’s coordination partner for sourcing Sputnik V…